We are live on
!
Find out more
Boston Partners Portfolio holdings
AUM
$113B
1-Year Est. Return
38.87%
This Fund
S&P 500
This Quarter
Est. Return
-14.15%
1 Year Est. Return
+38.87%
3 Year Est. Return
+108.29%
5 Year Est. Return
+142.95%
10 Year Est. Return
+500.61%
AUM
$69.6B
AUM Growth
-$16.5B
(-19%)
Cap. Flow
-$3.3B
Cap. Flow
% of AUM
-4.75%
Top 10 Holdings %
Top 10 Hldgs %
17.71%
Holding
779
New
83
Increased
294
Reduced
313
Closed
76
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$753M |
| 2 |
Marathon Petroleum
MPC
|
+$374M |
| 3 |
Target
TGT
|
+$361M |
| 4 |
WBA
Walgreens Boots Alliance
WBA
|
+$299M |
| 5 |
Huntington Bancshares
HBAN
|
+$242M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ANDV
Andeavor
ANDV
|
+$1.05B |
| 2 |
Merck
MRK
|
+$702M |
| 3 |
Bank of America
BAC
|
+$542M |
| 4 |
Oracle
ORCL
|
+$528M |
| 5 |
Steel Dynamics
STLD
|
+$499M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 26.74% |
| 2 | Healthcare | 14.95% |
| 3 | Industrials | 13.38% |
| 4 | Technology | 12.24% |
| 5 | Energy | 6.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MOMO
251
Hello Group
MOMO
$839M
| $37.3M | 0.05% |
1,571,247
-66,013
| -4% | -$2.08M |
|
|
NFX
252
DELISTED
Newfield Exploration
NFX
| $37.3M | 0.05% |
2,544,625
+1,286,111
| +102% | +$25.9M |
|
|
EFOR
253
Everforth Inc
EFOR
$1.3B
| $36.7M | 0.05% |
673,656
+42,727
| +7% | +$2.79M |
|
254
General Dynamics
GD
$102B
| $36.1M | 0.05% |
229,665
-9,648
| -4% | -$1.73M |
|
|
BMCH
255
DELISTED
BMC Stock Holdings, Inc
BMCH
| $36M | 0.05% |
2,327,857
-8,264
| -0.4% | -$138K |
|
256
KT
KT
$9.28B
| $36M | 0.05% |
2,531,235
+6,725
| +0.3% | +$97.4K |
|
257
Alibaba
BABA
$295B
| $35.8M | 0.05% |
260,831
+90,651
| +53% | +$13.4M |
|
258
Minerals Technologies
MTX
$2.24B
| $35.7M | 0.05% |
694,919
+44,497
| +7% | +$2.48M |
|
259
Cactus
WHD
$4.79B
| $35.5M | 0.05% |
1,296,327
-82,826
| -6% | -$2.71M |
|
|
NCI
260
DELISTED
Navigant Consulting, Inc.
NCI
| $35.4M | 0.05% |
1,472,485
+94,722
| +7% | +$2.17M |
|
|
TPC
261
Tutor Perini Cor
TPC
$4.71B
| $35.2M | 0.05% |
2,203,573
-568,081
| -20% | -$9.88M |
|
262
Azenta
AZTA
$1.44B
| $35.2M | 0.05% |
1,343,889
-677,822
| -34% | -$19.8M |
|
263
ABM Industries
ABM
$2.78B
| $34.8M | 0.05% |
1,083,605
+406,334
| +60% | +$12.4M |
|
264
TotalEnergies
TTE
$192B
| $34.5M | 0.05% |
+660,790
| New | +$37.9M |
|
265
Humana
HUM
$46.9B
| $33.4M | 0.05% |
+116,454
| New | +$36.9M |
|
266
Avnet
AVT
$7.32B
| $33M | 0.05% |
915,519
-1,403,154
| -61% | -$57.4M |
|
|
SYNH
267
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $32.7M | 0.05% |
830,227
+53,562
| +7% | +$2.49M |
|
|
ERF
268
DELISTED
Enerplus Corporation
ERF
| $32.6M | 0.05% |
4,205,934
-4,492,184
| -52% | -$43.7M |
|
269
ICF International
ICFI
$1.63B
| $31.8M | 0.05% |
491,551
+160,879
| +49% | +$11.3M |
|
270
Ecovyst
ECVT
$1.09B
| $31.6M | 0.05% |
2,136,564
+117,467
| +6% | +$1.8M |
|
271
Hanover Insurance
THG
$7.92B
| $31.5M | 0.05% |
269,631
-141,126
| -34% | -$15.8M |
|
272
First Citizens BancShares
FCNCA
$24.6B
| $31.4M | 0.05% |
83,155
-2,915
| -3% | -$1.22M |
|
|
SYKE
273
DELISTED
SYKES Enterprises Inc
SYKE
| $31.3M | 0.05% |
1,265,090
+83,866
| +7% | +$2.34M |
|
274
NCR Voyix
VYX
$1.22B
| $29.3M | 0.04% |
2,072,309
+370,061
| +22% | +$5.81M |
|
275
FirstCash
FCFS
$9.57B
| $29.1M | 0.04% |
402,268
-170,171
| -30% | -$13.6M |
|
Similar funds
Boston Partners's Q4 2018 Portfolio in Review
As of Q4 2018, Boston Partners held 779 positions worth $69.6B, down 19% from $86.1B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Boston Partners withdrew a net $3.3B in Q4 2018, closing 76 positions and reducing 313 holdings. Its most notable exit was Andeavor, an estimated $1.05B position sold in full.
By sector, the portfolio is most concentrated in Financials at 27% of assets, down from 28% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Boston Partners opened a new position in Procter & Gamble worth $775M.
- Boston Partners's largest Q4 2018 buy was Procter & Gamble: 8,428,522 shares worth $775M.
- Boston Partners added most to Marathon Petroleum in Q4 2018, an estimated $374M increase.
- Boston Partners's biggest Q4 2018 reduction was Merck, cutting an estimated $702M.
- Boston Partners fully exited Andeavor in Q4 2018, selling an estimated $1.05B.
- Boston Partners's ten largest holdings make up 18% of its $69.6B portfolio in Q4 2018.
- Boston Partners opened 83 new positions and closed 76 in Q4 2018.
- Boston Partners's portfolio value fell 19% quarter-over-quarter to $69.6B.
Based on Boston Partners's 13F filing for Q4 2018, filed 7 Feb 2019.